Search Results

The SternaFuse® Fixation System is indicated for use in the stabilization of fractures of the anterior chest wall, including stemal fixation following sternal fractures, and sternal reconstructive surgical procedures, to promote fusion. The device is for prescription use only.

The SternaFuse® Fixation System implants are composed of 316 LVM implant quality stainless steel plates, links, and screws intended to stabilize and fixate fractures of the anterior chest wall. The components include various sizes to facilitate customization according to the requirements of the anterior chest wall repair. Self-drilling locking screws come in two diameters, 3.0mm and 3.3mm, and lengths of 10mm, 13mm, and 16mm. Multiple plates may be used in one anterior chest wall repair. Variable Assemblies can be configured, and the Links angled for optimum fixation. Implants are designed with centralized saddles to aid in intra-operative contouring, to facilitate cutting during postoperative emergent re-entry, and to provide a location for stainless steel wire.

The implants are individually packaged and sterilized, allowing the surgeon to customize the desired implants for the specific needs of the patient. All implants are provided sterile with a five-year shelf-life. The implants should never be reused under any circumstance.

This document is a 510(k) premarket notification for a medical device called the SternaFuse® Fixation System. It details the device's indications for use, description, comparison to predicate devices, and performance data.

From the provided text, there is no information about a study that describes acceptance criteria or performance for an AI/CADeX device. The document focuses on a physical medical device (bone fixation system) and its mechanical, material, and sterility testing, not on software or AI performance.

Therefore, I cannot provide a table of acceptance criteria and reported device performance for an AI/CADeX device, nor can I answer questions about sample sizes, expert ground truth, adjudication methods, MRMC studies, standalone performance, or training/test set details for such a device from this document.

The "Performance Data" section (Section 9) exclusively discusses:

• Biocompatibility (Section 9.1): Assessed according to ISO 10993-1 for 316LVM Stainless Steel.
• Pyrogenicity/Endotoxin Testing (Section 9.2): Performed to meet acceptance criteria of <= 20 EU/device.
• Packaging/Sterility (Section 9.3): Validated according to ISO 11607-1 with transport simulation per ASTM D4169 and sterilization per ISO 11137.
• Mechanical Testing (Section 9.4): Includes Static Tension, Dynamic Tension, Screw Pullout (ASTM F543), Driving Torque (ASTM F543), and Torsion (ASTM F543).
• MR Safety Testing (Section 9.5): States the device has not been evaluated for safety, heating, migration, or compatibility in the MR environment.

Crucially, Section 9 also explicitly states: "There are no clinical data generated and held by the manufacturer, i.e., no premarketing or post-market clinical studies or animal studies have been performed." This further confirms the absence of any data relating to an AI's performance or a clinical study for software.

Ask a specific question about this device